MORE►
Eyevance
Marketing image for one of Eyevance Pharmaceuticals' products, Flarex. [eyevance.com]
Fort Worth Ophthalmic Biotech Eyevance Exits to Japanese Firm for $225M
by Alex Edwards | Sep 17, 2020
Eyevance Pharmaceuticals, which develops and commercializes ophthalmic products, has been purchased for $225 million by Santen, a Japanese leader in ophthalmology. Eyevance will join Santen's U.S. organization.
by Jeff Bounds |
Jan 21, 2020
Alcon gave rise to a startup ecosystem in North Texas that is spreading into all parts of how drugs, medical devices, and more are created.
MORE►
by Lance Murray |
Oct 25, 2018
You'll also find news from WiredScore, Jacobs Engineering, BNSF Railway and GE Transportation, as well as Bay Capital Ventures and Eyevance. Here are notable funding and acquisition deals with North Texas ties.
MORE►
